TECLens

🔒CT-based biotech TECLens aims to make reading glasses optional

Stamford biotech TECLens is testing a new approach to presbyopia after raising $5.2 million to advance its clinical development.
ADVERTISEMENT

Latest Stories

More Business News

Thought Leadership

More Thought Leadership
ADVERTISEMENT

Movers & Shakers

More Movers & Shakers | Submit Movers & Shakers

Business Announcements

More Announcements | Submit Business Announcements
More Events | Submit an Event